or Try an Advanced Search...

    Pharmaceutical Industry In China Stocks List

    Symbol Grade Name % Change
    CAH F Cardinal Health, Inc. -3.95
    CDMO B Avid Bioservices, Inc. 0.61
    CDT F Conduit Pharmaceuticals Inc. 0.33
    CNSP F CNS Pharmaceuticals, Inc. 2.60
    COSM F Cosmos Health Inc. 0.64
    ETON D Eton Pharmaceutcials, Inc. -1.07
    HCM B Hutchison China MediTech Limited -2.10
    HROW F Harrow Health, Inc. -2.44
    KNSA C Kiniksa Pharmaceuticals, Ltd. 3.61
    MEDS D TRxADE Group, Inc. 4.66
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Distribution Pharmaceutical Retailers Scientific & Technical Instruments
    Related Stock Lists: Pharmaceutical Pharmacy Biopharmaceutical Biotechnology Medicine Pharmacy In China Retail Pharmacies Acid Allergic Conjunctivitis Antibodies Autoimmune Disease Baby Products Beauty Care Products Beverage Blastoma Brain Tumor Cancer Central Nervous System Tumors Chargeback Clinical Trial

    Related ETFs - A few ETFs which own one or more of the above listed Pharmaceutical Industry In China stocks.

    Symbol Grade Name Weight
    FLSW C Franklin FTSE Switzerland ETF 12.84
    EWL C iShares MSCI Switzerland Capped Index Fund 12.72
    XPH D SPDR S&P Pharmaceuticals ETF 9.89
    PILL D Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF 8.14
    PPH C Market Vectors Pharmaceutical ETF 7.39
    View all Pharmaceutical Industry In China ETFs...
    Compare ETFs
    Compare EWL to PILL Compare FLSW to EWL Compare XPH to PILL

        Pharmaceutical Industry In China Stocks Recent News

        Date Stock Title
        May 3 CAH This Is What Whales Are Betting On Cardinal Health
        May 3 CAH Cardinal Health, Inc. (NYSE:CAH) Q3 2024 Earnings Call Transcript
        May 3 CAH Cardinal Health Third Quarter 2024 Earnings: Misses Expectations
        May 3 CAH Cardinal Health Q3 Earnings: Undervalued On Strong Guidance
        May 3 CDMO How Novo-Catalent Deal Affects Halozyme (HALO)?
        May 3 CAH Cardinal Health Inc (CAH) (Q3 2024) Earnings Call Transcript Highlights: Strong Growth and ...
        May 2 CAH Cardinal receives FDA warning letter over unapproved syringes
        May 2 HROW Harrow: Merits A Buy On Sales Potential
        May 2 CAH Cardinal Health, Inc. 2024 Q3 - Results - Earnings Call Presentation
        May 2 CAH Cardinal Health, Inc. (CAH) Q3 2024 Earnings Call Transcript
        May 2 CAH Compared to Estimates, Cardinal (CAH) Q3 Earnings: A Look at Key Metrics
        May 2 CAH Cardinal Health (CAH) Beats on Q3 Earnings, Ups '24 EPS View
        May 2 CAH Cardinal Health lifts 2024 profit view on demand for costly specialty drugs
        May 2 CAH Cardinal Health Inc (CAH) Q3 Earnings: Surpasses Analyst EPS Forecasts and Raises FY24 Guidance
        May 2 CAH Cardinal Health Non-GAAP EPS of $2.08 beats by $0.13, revenue of $54.9B misses by $1.21B
        May 2 CAH Cardinal Health Reports Third Quarter Fiscal Year 2024 Results and Raises Fiscal Year 2024 Non-GAAP EPS Guidance
        May 2 HROW Harrow: The Bull Thesis Is On Track, But Short-Term Challenges Loom
        May 1 ETON Eton Pharmaceuticals to Present at the Citizens JMP Life Sciences Conference
        May 1 CAH What You Should Know About Block (SQ) Ahead of Q1 Earnings
        May 1 CAH What's in Store for These 5 Medical Device Stocks in Q1 Earnings?
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Distribution Pharmaceutical Retailers Scientific & Technical Instruments
        Related Stock Lists: Pharmaceutical Pharmacy Biopharmaceutical Biotechnology Medicine Pharmacy In China Retail Pharmacies Acid Allergic Conjunctivitis Antibodies Autoimmune Disease Baby Products Beauty Care Products Beverage Blastoma Brain Tumor Cancer Central Nervous System Tumors Chargeback Clinical Trial
        Pharmaceutical Industry In China

        Browse All Tags